Overview
Valentin Hacker practices practicing medicine in Vienna, Austria.
His clinical expertise encompasses Blau Syndrome, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration.
He is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Valentin Hacker
Is Valentin Hacker a top-rated expert for Blau Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Valentin Hacker is classified as an Experienced expert for Blau Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Valentin Hacker participate in research or clinical trials?
Yes. Valentin Hacker has published 10 articles and abstracts on conditions like Blau Syndrome. You can view a list of Valentin Hacker's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Age-Related Macular Degeneration (ARMD)Mr. Hacker isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- Blau SyndromeMr. Hacker isExperienced. Learn about Blau Syndrome.
- Late-Onset Retinal DegenerationMr. Hacker isExperienced. Learn about Late-Onset Retinal Degeneration.